ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Pfizer Specialty UK Limited

Pfizer Specialty UK Limited is a liquidation company incorporated on 26 January 2009 with the registered office located in London, Greater London. Pfizer Specialty UK Limited was registered 16 years ago.
Status
Liquidation
In voluntary liquidation since 14 days ago
Company No
06801717
Private limited company
Age
16 years
Incorporated 26 January 2009
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Due Soon
Dated 10 January 2025 (1 year ago)
Next confirmation dated 10 January 2026
Due by 24 January 2026 (2 days remaining)
Last change occurred 2 years ago
Accounts
Submitted
For period 1 Dec30 Nov 2023 (12 months)
Accounts type is Full
Next accounts for period 31 May 2025
Due by 28 February 2026 (1 month remaining)
Contact
Address
1 More London Place
London
SE1 2AF
Address changed on 6 Jan 2026 (15 days ago)
Previous address was
Telephone
01304616161
Email
Unreported
Website
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Director • British • Lives in England • Born in Jan 1974
Director • British • Lives in England • Born in Jul 1968
Pfizer INC
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Pfizer Consumer Healthcare
David Ian Highton and Edwin James Pearson are mutual people.
Active
John Wyeth & Brother Limited
David Ian Highton and Edwin James Pearson are mutual people.
Active
Pharmacia Limited
David Ian Highton and Edwin James Pearson are mutual people.
Active
Pfizer Limited
David Ian Highton and Edwin James Pearson are mutual people.
Active
Pfizer Development Services (UK) Limited
David Ian Highton and Edwin James Pearson are mutual people.
Active
Pfizer R&D UK Limited
David Ian Highton and Edwin James Pearson are mutual people.
Active
Hospira UK Limited
David Ian Highton is a mutual person.
Active
MPP Trustee Limited
David Ian Highton is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2014–2023)
Period Ended
30 Nov 2023
For period 30 Nov30 Nov 2023
Traded for 12 months
Cash in Bank
£42K
Decreased by £420K (-91%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£7.18M
Decreased by £307.34M (-98%)
Total Liabilities
-£164K
Decreased by £383.04M (-100%)
Net Assets
£7.02M
Increased by £75.7M (-110%)
Debt Ratio (%)
2%
Decreased by 119.55% (-98%)
Latest Activity
Voluntary Liquidator Appointed
14 Days Ago on 7 Jan 2026
Declaration of Solvency
14 Days Ago on 7 Jan 2026
Inspection Address Changed
15 Days Ago on 6 Jan 2026
Registers Moved To Inspection Address
15 Days Ago on 6 Jan 2026
Registered Address Changed
28 Days Ago on 24 Dec 2025
Accounting Period Extended
6 Months Ago on 24 Jul 2025
Confirmation Submitted
1 Year Ago on 21 Jan 2025
Full Accounts Submitted
1 Year 5 Months Ago on 8 Aug 2024
Confirmation Submitted
2 Years Ago on 17 Jan 2024
Full Accounts Submitted
2 Years 5 Months Ago on 22 Aug 2023
Get Credit Report
Discover Pfizer Specialty UK Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Appointment of a voluntary liquidator
Submitted on 7 Jan 2026
Resolutions
Submitted on 7 Jan 2026
Declaration of solvency
Submitted on 7 Jan 2026
Register inspection address has been changed from Pfizer Dorking Road Tadworth Surrey KT20 7NS United Kingdom to Walton Oaks Dorking Road Tadworth Surrey KT20 7NS
Submitted on 6 Jan 2026
Register(s) moved to registered inspection location Walton Oaks Dorking Road Tadworth Surrey KT20 7NS
Submitted on 6 Jan 2026
Registered office address changed from Pfizer Ramsgate Road Sandwich Kent CT13 9NJ to 1 More London Place London SE1 2AF on 24 December 2025
Submitted on 24 Dec 2025
Resolutions
Submitted on 15 Dec 2025
Solvency Statement dated 15/12/25
Submitted on 15 Dec 2025
Statement by Directors
Submitted on 15 Dec 2025
Statement of capital on 15 December 2025
Submitted on 15 Dec 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year